HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chordoma characterization of significant changes of the DNA methylation pattern.

Abstract
Chordomas are rare mesenchymal tumors occurring exclusively in the midline from clivus to sacrum. Early tumor detection is extremely important as these tumors are resistant to chemotherapy and irradiation. Despite continuous research efforts surgical excision remains the main treatment option. Because of the often challenging anatomic location early detection is important to enable complete tumor resection and to reduce the high incidence of local recurrences. The aim of this study was to explore whether DNA methylation, a well known epigenetic marker, may play a role in chordoma development and if hypermethylation of specific CpG islands may serve as potential biomarkers correlated with SNP analyses in chordoma. The study was performed on tumor samples from ten chordoma patients. We found significant genomic instability by Affymetrix 6.0. It was interesting to see that all chordomas showed a loss of 3q26.32 (PIK 3CA) and 3q27.3 (BCL6) thus underlining the potential importance of the PI3K pathway in chordoma development. By using the AITCpG360 methylation assay we elucidated 20 genes which were hyper/hypomethylated compared to normal blood. The most promising candidates were nine hyper/hypomethylated genes C3, XIST, TACSTD2, FMR1, HIC1, RARB, DLEC1, KL, and RASSF1. In summary, we have shown that chordomas are characterized by a significant genomic instability and furthermore we demonstrated a characteristic DNA methylation pattern. These findings add new insights into chordoma development, diagnosis and potential new treatment options.
AuthorsBeate Rinner, Andreas Weinhaeusel, Birgit Lohberger, Elke Verena Froehlich, Walter Pulverer, Carina Fischer, Katharina Meditz, Susanne Scheipl, Slave Trajanoski, Christian Guelly, Andreas Leithner, Bernadette Liegl
JournalPloS one (PLoS One) Vol. 8 Issue 3 Pg. e56609 ( 2013) ISSN: 1932-6203 [Electronic] United States
PMID23533570 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Neoplasm
  • Cell Adhesion Molecules
  • DLEC1 protein, human
  • FMR1 protein, human
  • HIC1 protein, human
  • Kruppel-Like Transcription Factors
  • RASSF1 protein, human
  • RNA, Long Noncoding
  • Receptors, Retinoic Acid
  • TACSTD2 protein, human
  • Tumor Suppressor Proteins
  • XIST non-coding RNA
  • retinoic acid receptor beta
  • Fragile X Mental Retardation Protein
Topics
  • Adult
  • Aged
  • Antigens, Neoplasm (genetics)
  • Cell Adhesion Molecules (genetics)
  • Chordoma (genetics)
  • DNA Methylation (genetics)
  • Female
  • Fragile X Mental Retardation Protein (genetics)
  • Humans
  • Kruppel-Like Transcription Factors (genetics)
  • Male
  • Middle Aged
  • Oligonucleotide Array Sequence Analysis
  • RNA, Long Noncoding (genetics)
  • Receptors, Retinoic Acid (genetics)
  • Tumor Suppressor Proteins (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: